Swedish Rare Disease Pharma Biz Ends Takeover Talks
Swedish pharmaceutical company Egetis Therapeutics AB said on Wednesday that it has ended discussions for a potential sale with unnamed "external parties" after concluding that the proposed offer was not financially...To view the full article, register now.
Already a subscriber? Click here to view full article